Battles Over Medication Abortion Threaten the Integrity of Drug Approvals in the U.S

&
Journal of Law, Medicine and Ethics 51 (2):448-449 (2023)
  Copy   BIBTEX

Abstract

Legal challenges to the FDA’s approval of mifepristone have destabilized patients’ ability to access controversial medicines like medication abortion. We argue that federal courts’ receptiveness to this litigation undermines the coherence and integrity of prescription drug regulation in the U.S.

Categories

Keywords

Reprint years

DOI

10.1017/jme.2023.76

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,438

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

A multi‐intervention approach on drug therapy can lead to a more appropriate drug use in the elderly. LIMM‐Landskrona Integrated Medicines Management.Anna Bergkvist, Patrik Midlöv, Peter Höglund, Lisa Larsson & Tommy Eriksson - 2009 - Journal of Evaluation in Clinical Practice 15 (4):660-667.
Cost‐effectiveness of an electronic medication ordering and administration system in reducing adverse drug events.Robert C. Wu, Audrey Laporte & Wendy J. Ungar - 2007 - Journal of Evaluation in Clinical Practice 13 (3):440-448.
Surrogate Endpoints and Drug Regulation: What Is Needed to Clarify the Evidence.Spencer Phillips Hey, William B. Feldman, Emily H. Jung, Elvira D'Andrea & Aaron S. Kesselheim - 2019 - Journal of Law, Medicine and Ethics 47 (3):381-387.
Drug Trials, Doctors, and Developing Countries: Toward a Legal Definition of Informed Consent.Adina M. Newman - 1996 - Cambridge Quarterly of Healthcare Ethics 5 (3):387.
Confronting medication scarcity in the era of COVID-19.Yoram Unguru - 2022 - Clinical Ethics 17 (1):83-86.
Departing ways: Uniformity, disparity, and cooperation in federal drug sentences.Michael A. Simons - unknown
Drug use as consumer behavior.Gordon Robert Foxall & Valdimar Sigurdsson - 2011 - Behavioral and Brain Sciences 34 (6):313-314.
What Do We Mean When We Call Someone a Drug Addict?Janet Jones - 2020 - Health Care Analysis 28 (4):391-403.
Drug legalization.Douglas N. Husak - 2007 - In Rosamond Rhodes, Leslie Francis & Anita Silvers (eds.), The Blackwell Guide to Medical Ethics. Oxford, UK: Blackwell. pp. 238–253.
Justified deception? The single blind placebo in drug research.M. Evans - 2000 - Journal of Medical Ethics 26 (3):188-193.
The Expanded Access Cure: A Twenty-First Century Framework for Companies.Alexandra Y. Murata & Stacey B. Lee - 2019 - Journal of Business Ethics 156 (1):155-171.
A retrospective study of drug‐related problems in Australian aged care homes: medication reviews involving pharmacists and general practitioners.Prasad S. Nishtala, Andrew J. McLachlan, J. Simon Bell & Timothy F. Chen - 2011 - Journal of Evaluation in Clinical Practice 17 (1):97-103.
生命的哲学 ‐后基因时代药物筛选策略与传统中药学理论.Xiao Ming Wang - 2008 - Proceedings of the Xxii World Congress of Philosophy 44:139-142.
Nanotechnology targeting drug delivery with biosensor - a review.Mohammed I. Majeed & Hayder T. Qaddoori - unknown
Three arguments against prescription requirements.Jessica Flanigan - 2012 - Journal of Medical Ethics 38 (10):579-586.

Analytics

Added to PP
2023-09-02

Downloads
17 (#854,714)

6 months
12 (#204,232)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references